Does DACTINOMYCIN Cause Product use in unapproved indication? 203 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 203 reports of Product use in unapproved indication have been filed in association with DACTINOMYCIN (DACTINOMYCIN). This represents 7.1% of all adverse event reports for DACTINOMYCIN.
203
Reports of Product use in unapproved indication with DACTINOMYCIN
7.1%
of all DACTINOMYCIN reports
45
Deaths
17
Hospitalizations
How Dangerous Is Product use in unapproved indication From DACTINOMYCIN?
Of the 203 reports, 45 (22.2%) resulted in death, 17 (8.4%) required hospitalization, and 8 (3.9%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DACTINOMYCIN. However, 203 reports have been filed with the FAERS database.
What Other Side Effects Does DACTINOMYCIN Cause?
Off label use (391)
Febrile neutropenia (226)
Neutropenia (205)
Drug ineffective (181)
Disease progression (151)
Vomiting (119)
Anaemia (109)
Thrombocytopenia (106)
Malignant neoplasm progression (103)
Stomatitis (103)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which DACTINOMYCIN Alternatives Have Lower Product use in unapproved indication Risk?
DACTINOMYCIN vs DALBAVANCIN
DACTINOMYCIN vs DALFAMPRIDINE
DACTINOMYCIN vs DALTEPARIN
DACTINOMYCIN vs DAMOCTOCOG ALFA PEGOL
DACTINOMYCIN vs DANAPAROID